Mayne Pharma | MYX - Ebit

Stock Price
2.57
Daily Change
0.02 0.59%
Monthly
-9.36%
Yearly
-64.42%
Q1 Forecast
2.59

Mayne Pharma reported AUD-16.2M in EBIT for its fiscal semester ending in June of 2024.





Ebit Change Date
Ansell USD 117.3M 39.1M Jun/2024
Avita Medical AUD -8.66M 1.61M Jun/2025
Cochlear AUD 275M 25.5M Dec/2024
CSL USD 2.75B 1.35B Dec/2024
Healius AUD 23.7M 26M Dec/2024
Integral Diagnostics AUD 24.99M 5.08M Jun/2024
Medical Developments International AUD -12.12M 3.97M Jun/2023
Nanosonics AUD 8.7M 2.6M Dec/2024
Polynovo AUD 840K 147K Jun/2024
Ramsay Health Care AUD 500.1M 14.8M Dec/2024
ResMed USD 497.6M 35.25M Dec/2025
Sigma Healthcare AUD 809K 13.76M Dec/2024
Sonic Healthcare AUD 423.94M 80.3M Dec/2024
Telix Pharmaceuticals AUD 8.04M 3.21M Dec/2025